Obsidian Therapeutics, Inc. (OBX)
NCM · Healthcare · Biotechnology
$13.94
+0.07%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$861.1M
Shares Outstanding
61.8M
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (26.6M) | (20.3M) |
| Net Income | (25.0M) | (19.6M) |
| Diluted EPS | $-0.41 | $-0.32 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (91.3M) | (105.7M) |
| Net Income | (83.1M) | (100.6M) |
| Diluted EPS | $-1.35 | $-1.63 |